YOUR BUSINESS AUTHORITY
Springfield, MO
YOUR BUSINESS AUTHORITY
Springfield, MO
Generic drug manufacturer Mallinckrodt Pharmaceuticals reached a tentative deal to settle opioid claims.
Through the deal, Mallinckrodt would pay a $1.6 billion settlement and enter its generics business into Chapter 11 bankruptcy.
The settlement comes amid thousands of lawsuits in a federal case that seeks to determine who should be held financially liable for the impact of the opioid crisis.
Read more from The Washington Post.
This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.
Banker pleads guilty to fraud scheme
Longtime employee sues Ozarks Tech, alleges retaliation
Cavender’s opens hat shop in southeast Springfield
Caterpillar to acquire John Fabick Tractor Co.
Eric Schmitt introduces Modern Skies Act
Springfield airport to cut the ribbon on $35M in construction projects